Annals of Neurology Journal - May 2012 - (Page 652k) DIGITAL ONLY Supplemental content for: Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (642–652) 8. Balance Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2) (NCS Pearson, Upper Saddle River, NJ, USA): Balance subtest. Background/Purpose: The BOT-2 is an individually administered test that uses engaging, goal-directed activities to measure a wide array of motor skills in individuals <21 years. We are using the BOT-2 subtest of balance. Tests of standing and walking balance include: standing with feet apart on a line (eyes open/closed); walking forward on a line and walking forward heel-to-toe on a line; standing on one leg on a line (eyes open/closed); standing on one leg on a balance beam (eyes open/closed); and standing heel-totoe on a balance beam.16 The BOT-2 incorporates age-equivalent normative data and is regarded as a reliable and valid measure of motor ability.17 Course set-up General Directions Perform using the portion of the running course from the ‘examiner throwing line’ to the ‘end line’ and the target on the wall (see diagram above). Place the target on the wall at the appropriate level for the child’s height, with the bottom of the target at the examiner’s eye level. For items using the balance beam, place the beam at the ‘end line’. For each item, conduct a second trial only if the child does not earn the maximum score on their first trial. Before administering each item, teach the task to the child using verbal and non-verbal directions as necessary to ensure the child’s understanding of the task. Tests should be performed barefoot and without an assistive device. If assistive devices are required (e.g. AFO) they should be clearly documented with footwear details, and repeated at follow-up. For those unable to perform Balance due to CMT severity, score 0 Points. See over the page for BOT-2 Balance Subtest Instructions: 11 © J Burns et al and the Inherited Neuropathies Consortium 2011 continued on next page Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article. Table of Contents for the Digital Edition of Annals of Neurology Journal - May 2012 Annals of Neurology Journal - May 2012 Contents Multiple Sclerosis Drugs: Sticker Shock Genomic Testing Update Discoveries in Neuroscience Cerebrospinal Fluid Proteomics: A New Window for Understanding Human Demyelinating Disorders? Cell Therapy for Neonatal Hypoxia–Ischemia and Cerebral Palsy Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders Rapid Communication: Thrombolysis With Recombinant Tissue Plasminogen Activator Under Dabigatran Anticoagulation in Experimental Stroke Symptomatic Intracranial Hemorrhage After Stroke Thrombolysis: The Sedan Score Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability Childhood Socioeconomic Status and Adult Brain Size: Childhood Socioeconomic Status Influences Adult Hippocampal Size Excessive Daytime Sleepiness and Vascular Events: The Three City Study Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory Losartan, a Therapeutic Candidate in Congenital Muscular Dystrophy: Studies in the Dy2j/dy2j Mouse Carotid Plaque Inflammation on 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Early Stroke Recurrence Homozygous Deletion of an Egr2 Enhancer in Congenital Amyelinating Neuropathy Hydrocarbon Solvent Exposure and Parkinson Disease Assessing Bioequivalence of Generic Antiepilepsy Drugs by Indirect Comparisons Reply Angiogenin Variation and Parkinson Disease Angiogenin, a Piece of the Complex Puzzle of Neurodegeneration Erratum Annals of Neurology Journal - May 2012 Annals of Neurology Journal - May 2012 - (Page Intro) Annals of Neurology Journal - May 2012 - (Page i) Annals of Neurology Journal - May 2012 - Annals of Neurology Journal - May 2012 (Page Cover1) Annals of Neurology Journal - May 2012 - Annals of Neurology Journal - May 2012 (Page Cover2) Annals of Neurology Journal - May 2012 - Annals of Neurology Journal - May 2012 (Page A1) Annals of Neurology Journal - May 2012 - Contents (Page A2) Annals of Neurology Journal - May 2012 - Contents (Page A3) Annals of Neurology Journal - May 2012 - Contents (Page A4) Annals of Neurology Journal - May 2012 - Multiple Sclerosis Drugs: Sticker Shock (Page A5) Annals of Neurology Journal - May 2012 - Multiple Sclerosis Drugs: Sticker Shock (Page A6) Annals of Neurology Journal - May 2012 - Genomic Testing Update (Page A7) Annals of Neurology Journal - May 2012 - Genomic Testing Update (Page A8) Annals of Neurology Journal - May 2012 - Genomic Testing Update (Page A9) Annals of Neurology Journal - May 2012 - Discoveries in Neuroscience (Page A10) Annals of Neurology Journal - May 2012 - Cerebrospinal Fluid Proteomics: A New Window for Understanding Human Demyelinating Disorders? (Page 587) Annals of Neurology Journal - May 2012 - Cerebrospinal Fluid Proteomics: A New Window for Understanding Human Demyelinating Disorders? (Page 588) Annals of Neurology Journal - May 2012 - Cell Therapy for Neonatal Hypoxia–Ischemia and Cerebral Palsy (Page 589) Annals of Neurology Journal - May 2012 - Cell Therapy for Neonatal Hypoxia–Ischemia and Cerebral Palsy (Page 590) Annals of Neurology Journal - May 2012 - Cell Therapy for Neonatal Hypoxia–Ischemia and Cerebral Palsy (Page 591) Annals of Neurology Journal - May 2012 - Cell Therapy for Neonatal Hypoxia–Ischemia and Cerebral Palsy (Page 592) Annals of Neurology Journal - May 2012 - Cell Therapy for Neonatal Hypoxia–Ischemia and Cerebral Palsy (Page 593) Annals of Neurology Journal - May 2012 - Cell Therapy for Neonatal Hypoxia–Ischemia and Cerebral Palsy (Page 594) Annals of Neurology Journal - May 2012 - Cell Therapy for Neonatal Hypoxia–Ischemia and Cerebral Palsy (Page 595) Annals of Neurology Journal - May 2012 - Cell Therapy for Neonatal Hypoxia–Ischemia and Cerebral Palsy (Page 596) Annals of Neurology Journal - May 2012 - Cell Therapy for Neonatal Hypoxia–Ischemia and Cerebral Palsy (Page 597) Annals of Neurology Journal - May 2012 - Cell Therapy for Neonatal Hypoxia–Ischemia and Cerebral Palsy (Page 598) Annals of Neurology Journal - May 2012 - Cell Therapy for Neonatal Hypoxia–Ischemia and Cerebral Palsy (Page 599) Annals of Neurology Journal - May 2012 - Cell Therapy for Neonatal Hypoxia–Ischemia and Cerebral Palsy (Page 600) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 601) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 602) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 603) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 604) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 605) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 606) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 607) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 608) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 609) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 610) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 611) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 612) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 613) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 613a) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 613b) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 613c) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 613d) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 613e) Annals of Neurology Journal - May 2012 - Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple Sclerosis (Page 613f) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 614) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 615) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 616) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 617) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 618) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 619) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 620) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 621) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 622) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 623) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 623a) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 623b) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 623c) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 623d) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 623e) Annals of Neurology Journal - May 2012 - Proteomic Pattern Analysis Discriminates Among Multiple Sclerosis–Related Disorders (Page 623f) Annals of Neurology Journal - May 2012 - Rapid Communication: Thrombolysis With Recombinant Tissue Plasminogen Activator Under Dabigatran Anticoagulation in Experimental Stroke (Page 624) Annals of Neurology Journal - May 2012 - Rapid Communication: Thrombolysis With Recombinant Tissue Plasminogen Activator Under Dabigatran Anticoagulation in Experimental Stroke (Page 625) Annals of Neurology Journal - May 2012 - Rapid Communication: Thrombolysis With Recombinant Tissue Plasminogen Activator Under Dabigatran Anticoagulation in Experimental Stroke (Page 626) Annals of Neurology Journal - May 2012 - Rapid Communication: Thrombolysis With Recombinant Tissue Plasminogen Activator Under Dabigatran Anticoagulation in Experimental Stroke (Page 627) Annals of Neurology Journal - May 2012 - Rapid Communication: Thrombolysis With Recombinant Tissue Plasminogen Activator Under Dabigatran Anticoagulation in Experimental Stroke (Page 628) Annals of Neurology Journal - May 2012 - Rapid Communication: Thrombolysis With Recombinant Tissue Plasminogen Activator Under Dabigatran Anticoagulation in Experimental Stroke (Page 629) Annals of Neurology Journal - May 2012 - Rapid Communication: Thrombolysis With Recombinant Tissue Plasminogen Activator Under Dabigatran Anticoagulation in Experimental Stroke (Page 630) Annals of Neurology Journal - May 2012 - Rapid Communication: Thrombolysis With Recombinant Tissue Plasminogen Activator Under Dabigatran Anticoagulation in Experimental Stroke (Page 631) Annals of Neurology Journal - May 2012 - Rapid Communication: Thrombolysis With Recombinant Tissue Plasminogen Activator Under Dabigatran Anticoagulation in Experimental Stroke (Page 632) Annals of Neurology Journal - May 2012 - Rapid Communication: Thrombolysis With Recombinant Tissue Plasminogen Activator Under Dabigatran Anticoagulation in Experimental Stroke (Page 633) Annals of Neurology Journal - May 2012 - Rapid Communication: Thrombolysis With Recombinant Tissue Plasminogen Activator Under Dabigatran Anticoagulation in Experimental Stroke (Page 633a) Annals of Neurology Journal - May 2012 - Symptomatic Intracranial Hemorrhage After Stroke Thrombolysis: The Sedan Score (Page 634) Annals of Neurology Journal - May 2012 - Symptomatic Intracranial Hemorrhage After Stroke Thrombolysis: The Sedan Score (Page 635) Annals of Neurology Journal - May 2012 - Symptomatic Intracranial Hemorrhage After Stroke Thrombolysis: The Sedan Score (Page 636) Annals of Neurology Journal - May 2012 - Symptomatic Intracranial Hemorrhage After Stroke Thrombolysis: The Sedan Score (Page 637) Annals of Neurology Journal - May 2012 - Symptomatic Intracranial Hemorrhage After Stroke Thrombolysis: The Sedan Score (Page 638) Annals of Neurology Journal - May 2012 - Symptomatic Intracranial Hemorrhage After Stroke Thrombolysis: The Sedan Score (Page 639) Annals of Neurology Journal - May 2012 - Symptomatic Intracranial Hemorrhage After Stroke Thrombolysis: The Sedan Score (Page 640) Annals of Neurology Journal - May 2012 - Symptomatic Intracranial Hemorrhage After Stroke Thrombolysis: The Sedan Score (Page 641) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 642) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 643) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 644) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 645) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 646) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 647) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 648) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 649) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 650) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 651) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652a) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652b) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652c) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652d) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652e) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652f) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652g) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652h) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652i) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652j) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652k) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652l) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652m) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652n) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652o) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652p) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652q) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652r) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652s) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652t) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652u) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652v) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652w) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652x) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652y) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652z) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652aa) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652ab) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652ac) Annals of Neurology Journal - May 2012 - Validation of the Charcot–Marie–Tooth Disease Pediatric Scale as an Outcome Measure of Disability (Page 652ad) Annals of Neurology Journal - May 2012 - Childhood Socioeconomic Status and Adult Brain Size: Childhood Socioeconomic Status Influences Adult Hippocampal Size (Page 653) Annals of Neurology Journal - May 2012 - Childhood Socioeconomic Status and Adult Brain Size: Childhood Socioeconomic Status Influences Adult Hippocampal Size (Page 654) Annals of Neurology Journal - May 2012 - Childhood Socioeconomic Status and Adult Brain Size: Childhood Socioeconomic Status Influences Adult Hippocampal Size (Page 655) Annals of Neurology Journal - May 2012 - Childhood Socioeconomic Status and Adult Brain Size: Childhood Socioeconomic Status Influences Adult Hippocampal Size (Page 656) Annals of Neurology Journal - May 2012 - Childhood Socioeconomic Status and Adult Brain Size: Childhood Socioeconomic Status Influences Adult Hippocampal Size (Page 657) Annals of Neurology Journal - May 2012 - Childhood Socioeconomic Status and Adult Brain Size: Childhood Socioeconomic Status Influences Adult Hippocampal Size (Page 658) Annals of Neurology Journal - May 2012 - Childhood Socioeconomic Status and Adult Brain Size: Childhood Socioeconomic Status Influences Adult Hippocampal Size (Page 659) Annals of Neurology Journal - May 2012 - Childhood Socioeconomic Status and Adult Brain Size: Childhood Socioeconomic Status Influences Adult Hippocampal Size (Page 660) Annals of Neurology Journal - May 2012 - Excessive Daytime Sleepiness and Vascular Events: The Three City Study (Page 661) Annals of Neurology Journal - May 2012 - Excessive Daytime Sleepiness and Vascular Events: The Three City Study (Page 662) Annals of Neurology Journal - May 2012 - Excessive Daytime Sleepiness and Vascular Events: The Three City Study (Page 663) Annals of Neurology Journal - May 2012 - Excessive Daytime Sleepiness and Vascular Events: The Three City Study (Page 664) Annals of Neurology Journal - May 2012 - Excessive Daytime Sleepiness and Vascular Events: The Three City Study (Page 665) Annals of Neurology Journal - May 2012 - Excessive Daytime Sleepiness and Vascular Events: The Three City Study (Page 666) Annals of Neurology Journal - May 2012 - Excessive Daytime Sleepiness and Vascular Events: The Three City Study (Page 667) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 668) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 669) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 670) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 671) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 672) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 673) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 674) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 675) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 676) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 677) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 678) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 679) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 680) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 681) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 682) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 683) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 684) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 685) Annals of Neurology Journal - May 2012 - Dynamics of Hemispheric Dominance for Language Assessed by Magnetoencephalographic Imaging (Page 686) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 687) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 688) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 689) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 690) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 691) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 692) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 693) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 694) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 695) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 696) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 697) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 698) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 698a) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 698b) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 698c) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 698d) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 698e) Annals of Neurology Journal - May 2012 - Anesthetics Isoflurane and Desflurane Differently Affect Mitochondrial Function, Learning, and Memory (Page 698f) Annals of Neurology Journal - May 2012 - Losartan, a Therapeutic Candidate in Congenital Muscular Dystrophy: Studies in the Dy2j/dy2j Mouse (Page 699) Annals of Neurology Journal - May 2012 - Losartan, a Therapeutic Candidate in Congenital Muscular Dystrophy: Studies in the Dy2j/dy2j Mouse (Page 700) Annals of Neurology Journal - May 2012 - Losartan, a Therapeutic Candidate in Congenital Muscular Dystrophy: Studies in the Dy2j/dy2j Mouse (Page 701) Annals of Neurology Journal - May 2012 - Losartan, a Therapeutic Candidate in Congenital Muscular Dystrophy: Studies in the Dy2j/dy2j Mouse (Page 702) Annals of Neurology Journal - May 2012 - Losartan, a Therapeutic Candidate in Congenital Muscular Dystrophy: Studies in the Dy2j/dy2j Mouse (Page 703) Annals of Neurology Journal - May 2012 - Losartan, a Therapeutic Candidate in Congenital Muscular Dystrophy: Studies in the Dy2j/dy2j Mouse (Page 704) Annals of Neurology Journal - May 2012 - Losartan, a Therapeutic Candidate in Congenital Muscular Dystrophy: Studies in the Dy2j/dy2j Mouse (Page 705) Annals of Neurology Journal - May 2012 - Losartan, a Therapeutic Candidate in Congenital Muscular Dystrophy: Studies in the Dy2j/dy2j Mouse (Page 706) Annals of Neurology Journal - May 2012 - Losartan, a Therapeutic Candidate in Congenital Muscular Dystrophy: Studies in the Dy2j/dy2j Mouse (Page 707) Annals of Neurology Journal - May 2012 - Losartan, a Therapeutic Candidate in Congenital Muscular Dystrophy: Studies in the Dy2j/dy2j Mouse (Page 708) Annals of Neurology Journal - May 2012 - Carotid Plaque Inflammation on 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Early Stroke Recurrence (Page 709) Annals of Neurology Journal - May 2012 - Carotid Plaque Inflammation on 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Early Stroke Recurrence (Page 710) Annals of Neurology Journal - May 2012 - Carotid Plaque Inflammation on 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Early Stroke Recurrence (Page 711) Annals of Neurology Journal - May 2012 - Carotid Plaque Inflammation on 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Early Stroke Recurrence (Page 712) Annals of Neurology Journal - May 2012 - Carotid Plaque Inflammation on 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Early Stroke Recurrence (Page 713) Annals of Neurology Journal - May 2012 - Carotid Plaque Inflammation on 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Early Stroke Recurrence (Page 714) Annals of Neurology Journal - May 2012 - Carotid Plaque Inflammation on 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Early Stroke Recurrence (Page 715) Annals of Neurology Journal - May 2012 - Carotid Plaque Inflammation on 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Early Stroke Recurrence (Page 716) Annals of Neurology Journal - May 2012 - Carotid Plaque Inflammation on 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Early Stroke Recurrence (Page 717) Annals of Neurology Journal - May 2012 - Carotid Plaque Inflammation on 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Early Stroke Recurrence (Page 718) Annals of Neurology Journal - May 2012 - Carotid Plaque Inflammation on 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Early Stroke Recurrence (Page 718a) Annals of Neurology Journal - May 2012 - Carotid Plaque Inflammation on 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Early Stroke Recurrence (Page 718b) Annals of Neurology Journal - May 2012 - Carotid Plaque Inflammation on 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Early Stroke Recurrence (Page 718c) Annals of Neurology Journal - May 2012 - Homozygous Deletion of an Egr2 Enhancer in Congenital Amyelinating Neuropathy (Page 719) Annals of Neurology Journal - May 2012 - Homozygous Deletion of an Egr2 Enhancer in Congenital Amyelinating Neuropathy (Page 720) Annals of Neurology Journal - May 2012 - Homozygous Deletion of an Egr2 Enhancer in Congenital Amyelinating Neuropathy (Page 721) Annals of Neurology Journal - May 2012 - Homozygous Deletion of an Egr2 Enhancer in Congenital Amyelinating Neuropathy (Page 722) Annals of Neurology Journal - May 2012 - Homozygous Deletion of an Egr2 Enhancer in Congenital Amyelinating Neuropathy (Page 723) Annals of Neurology Journal - May 2012 - Homozygous Deletion of an Egr2 Enhancer in Congenital Amyelinating Neuropathy (Page 723a) Annals of Neurology Journal - May 2012 - Homozygous Deletion of an Egr2 Enhancer in Congenital Amyelinating Neuropathy (Page 723b) Annals of Neurology Journal - May 2012 - Homozygous Deletion of an Egr2 Enhancer in Congenital Amyelinating Neuropathy (Page 723c) Annals of Neurology Journal - May 2012 - Homozygous Deletion of an Egr2 Enhancer in Congenital Amyelinating Neuropathy (Page 723d) Annals of Neurology Journal - May 2012 - Assessing Bioequivalence of Generic Antiepilepsy Drugs by Indirect Comparisons (Page 724) Annals of Neurology Journal - May 2012 - Angiogenin Variation and Parkinson Disease (Page 725) Annals of Neurology Journal - May 2012 - Angiogenin Variation and Parkinson Disease (Page 726) Annals of Neurology Journal - May 2012 - Angiogenin, a Piece of the Complex Puzzle of Neurodegeneration (Page 727) Annals of Neurology Journal - May 2012 - Erratum (Page 728) Annals of Neurology Journal - May 2012 - Erratum (Page 729) Annals of Neurology Journal - May 2012 - Erratum (Page 730) Annals of Neurology Journal - May 2012 - Erratum (Page 731) Annals of Neurology Journal - May 2012 - Erratum (Page Cover3) Annals of Neurology Journal - May 2012 - Erratum (Page Cover4) http://www.nxtbook.com/nxtbooks/wiley/annalsofneurolog_importantinfo http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201310 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201309 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201308 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201307 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201306 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201305 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201304 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201303 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201302 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201301 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201212 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201211 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201210 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201209 http://www.nxtbook.com/nxtbooks/wiley/clinicalhighlights_2012 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201208 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201207 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201206 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201205 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201204 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201203 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201202 http://www.nxtbook.com/nxtbooks/wiley/annalsofneurology_201201 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.